Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenC conjugate booster immunogenicity study in toddlers previously primed with TT- or CRM197-conjugated vaccine
2006-003525-82Phase 4Completed
- Sponsor
- Dirección General de Salud Pública
- Start
- Mar 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Meningococcal group C polysaccharide conjugate vaccine in meningococcal group C disease (4 arms), sponsored by Dirección General de Salud Pública. Primary endpoints: Primary immunogenicity endpoint and Non-inferiority endpoint. Started Mar 2010; status: completed.
02
Drugs
Meningococcal group C polysaccharide conjugate vaccine
03
Conditions
meningococcal group C disease
Beyond the preview
Go deeper on 2006-003525-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003525-82.